Managing Sepsis with Procalcitonin
Learn more about the challenges healthcare providers face treating patients with sepsis - particularly those with COVID-19. Data will be presented, and questions answered on the Atellica IM BRAHMS Procalcitonin assay.
After this webinar, participants will:
- Understand the definition of sepsis
- Identify the common biomarkers of sepsis
- Examine the clinical utility of an Atellica IM BRAHMS Procalcitonin assay
Monet Sayegh, MD, MHSc, BS, MT(ASCP)SH, CLS
Senior Clinical Consultant, Disease State Education
Dr. Sayegh has over 30 years of experience in the fields of medicine, research, abdominal laparoscopic surgery and clinical laboratory science. His background includes extensive research in immunology/allergy, hematology/oncology, endocrinology, special chemistry, HLA histocompatiblity and maternal screen. He is a senior clinical consultant and a member of the Disease State Education group at Siemens Healthineers, focusing on cardiovascular, oncology, and infectious diseases.
Available: October 7, 2020